From: Metabolomics and biomarkers for lupus nephritis – a systematic review
Biomarker | LN versus HC | LN versus SLE | |||||
---|---|---|---|---|---|---|---|
Variation | AUC | VIP | Variation | AUC | VIP | ||
Ganguly et al., 2020 | Citrate/creatine | ↓ | 0.9136 | ||||
Acetate/creatinine ratio | ↑ | 0.6883 | |||||
Li et al., 2017 | Theophylline | ↓ | 0.77 | 0.277 | |||
Oxidized glutathione | ↓ | 0.77 | 1.473 | ||||
Capric acid | ↑ | 0.74 | 1.486 | ||||
3-Indolepropionic acid | ↓ | 0.72 | 0.650 | ||||
Norvaline | ↓ | 0.75 | 0.630 | ||||
Hippuric acid | ↓ | 0.72 | 0.531 | ||||
Sphingosine | ↓ | 0.72 | 0.533 | ||||
Sorbitol | ↑ | 0.75 | 5.077 | ||||
Cortisol | ↓ | 0.73 | 0.486 | ||||
N-acetylglutamine | ↓ | 0.72 | 0.158 | ||||
Glucose 6-phosphate | ↓ | 0.70 | 0.124 | ||||
Riboflavin | ↓ | 0.70 | 0.738 | ||||
Taurine | ↓ | 0.67 | 0.368 | ||||
Creatinine | ↓ | 0.75 | 0.762 | ||||
Guleria et al., 2016 | Leucine | ↓ | 0.82 | 1.1 | — | - | — |
Valine | ↓ | 0.93 | 1.8 | — | - | — | |
Alanine | ↓ | 0.87 | 3.22 | — | - | — | |
Acetate | ↓ | 0.81 | 0.62 | ↓ | 1 | 1.44 | |
NAG | ↑ | 0.95 | 2.65 | — | - | — | |
Glutamate | ↓ | 0.98 | 1.42 | — | - | — | |
Citrate | ↓ | 0.99 | 0.89 | - | - | - | |
Choline | ↓ | 0.76 | 2.72 | ↑ | 0.82 | 4.53 | |
Proline | ↓ | 0.82 | 1.68 | — | - | — | |
Glycine | ↓ | 0.89 | 3.33 | — | - | — | |
Lactate | ↓ | 0.96 | 8.98 | ↑ | 0.75 | 3.13 | |
Glucose | ↑ | 0.80-0.99 | 1.00–6.30 | ↓ | 0.75-0.92 | 1.00–6.09 | |
Histidine | ↓ | 0.85 | 0.72 | — | - | — | |
L1\L2 | ↑ | 0.94 | 1.00–2.96 | ↑ | 0.98 | 1.00–2.59 | |
L3\L4 | ↑ | 0.98 | 2.00–10.1 | ↑ | 0.99 | 2.00–9.70 | |
L5 | ↑ | 0.87 | 0.78 | ↑ | 0.96 | 0.81 | |
L6 | ↑ | 0.92 | 1.5 | ↑ | 0.96 | 1.65 | |
L7 | ↑ | 0.88 | 1.06 | ↑ | 0.96 | 1.1 | |
L8 | ↑ | 0.83 | 0.37 | ↑ | 0.93 | 0.42 | |
L9 | ↑ | 0.96 | 1.4 | ↑ | 0.98 | 1.32 | |
Kalantari et al., 2019 | 4-Methylcatechol | ↑ | 0.73 | 1.4 | - | 0.61 | - |
DOPAL | ↑ | 0.72 | 1.3 | ↑ | 0.71 | 1.2 | |
Unknown | ↑ | 0.72 | 1 | - | 0.88 | - | |
2,2-DMS | ↓ | 0.87 | 1.3 | ↓ | 0.85 | 2.1 | |
Beta-alanine | ↓ | 0.9 | 1.3 | ↓ | 1.8 | ||
Nicotinamide ribotide (NMN) | - | 0.73 | - | ↑ | 1.13 | ||
Nicotinamide | - | 0.74 | - | ↑ | 1.16 | ||
Nicotinamide adenine dinucleotide (NAD) | - | 0.79 | - | ↑ | 1.5 | ||
Nicotinic acid | - | - | ↑ | 1.1 | |||
Guanosine triphosphate (GTP) | - | 0.73 | - | ↑ | 1.2 | ||
Epi-coprostanol | - | 0.74 | - | ↓ | 1.3 | ||
Pyridoxine | - | 0.68 | - | ↓ | 1.7 | ||
Hippuric acid | - | 0.8 | - | ↓ | 1.5 | ||
Anthranilic acid | - | 0.76 | - | ↓ | 1.8 | ||
Unknown | - | 0.74 | - | ↓ | 1.3 | ||
W. Zhang et al., 2022a | (10E,12Z)-(9S)-9-Hydroperoxyoctadeca-10,12-dienoic acid | ↓ | 1.424 | ||||
5,8,11-Eicosatrienoic acid | ↑ | 1.194 | |||||
cis-p-Coumaroylcorosolic acid | ↓ | 1.532 | |||||
Dolichosterone | ↓ | 1.865 | |||||
Ganoderiol H | ↓ | 1.702 | |||||
L-Hexanoylcarnitine | ↑ | 1.811 | |||||
Lycoperoside D | ↑ | 1.061 | |||||
Malonylcarnitine | ↑ | 1.403 | |||||
PS(14:1(9Z)/14:0) | ↓ | 1.078 | |||||
5'-Methylthioadenosine | ↑ | 1.119 | |||||
Orotidine | ↑ | 1.083 | |||||
2-Hydroxyethanesulfonate | ↑ | 1.997 | |||||
4-Hydroxy-2-oxobutanoic acid | ↓ | 1.373 | |||||
Alanyl-Leucine | ↑ | 1.998 | |||||
apo-[3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)] | ↑ | 1.733 | |||||
Asymmetric dimethylarginine | ↑ | 1.742 | |||||
Creatinine | ↑ | 1.598 | |||||
gamma-Glutamylleucine | ↑ | 1.453 | |||||
Homocysteine thiolactone | ↓ | 1.507 | |||||
Leucyl-Valine | ↓ | 1.816 | |||||
Serylcysteine | ↑ | 1.346 | |||||
Aldehydo-D-xylose | ↑ | 1.709 | |||||
myo-Inositol | ↑ | 1.407 | |||||
Threonic acid | ↑ | 1.377 | |||||
2,4,6,8-Decatetraenoic acid dehydropiperidide | ↑ | 1.642 | |||||
4-Amino-1-piperidinecarboxylic acid | ↑ | 1.558 | |||||
Allantoin | ↑ | 1.118 | |||||
Aloesol | ↓ | 1.546 | |||||
Mercaptopurine | ↑ | 1.767 | |||||
2,4,6,8-Decatetraenoic acid dehydropiperidide | ↑ | 1.642 | |||||
4-Amino-1-piperidinecarboxylic acid | ↑ | 1.558 | |||||
Allantoin | ↑ | 1.118 | |||||
Aloesol | ↓ | 1.546 | |||||
Mercaptopurine | ↑ | 1.767 | |||||
Methylimidazole acetaldehyde | ↑ | 1.577 | |||||
Methylimidazoleacetic acid | ↑ | 1.587 | |||||
N1-Methyl-4-pyridone-3-carboxamide | ↑ | 1.289 | |||||
Pyrazine | ↑ | 1.380 | |||||
Xanthine | ↑ | 1.604 | |||||
Y. Zhang et al., 2022 | DG (18:3(9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)/0:0) | ↑ | 2.45 | ||||
SM d34:2 | ↑ | 2.31 | |||||
1,5-Anhydro-4-deoxy-D-glycero-hex-3-en-2-ulose | ↑ | 2.04 | |||||
8-(4-Methoxy-2,3,6-trimethyl-phenyl)-6-methyl-octa-3,5-dien-2-one | ↑ | 2.00 | |||||
Cer-BDS d38:5 | ↑ | 1.90 | |||||
Phenylacetyl-L-glutamine | ↑ | 1.82 | |||||
a-Amino-g-cyanobutanoate | ↑ | 1.77 | |||||
Pro-Leu | ↑ | 1.75 | |||||
lysoDGTS 15:2 | ↑ | 1.73 | |||||
LDGTS 15:1 | ↑ | 1.64 | |||||
Glycidyloleate | ↑ | 1.53 | |||||
PE 34:1 | ↓ | 2.26 | |||||
1-Hexadecylthio-2-hexadecanoylamino-1,2-dideoxy-sn-glycero-3-phosphocholine | ↓ | 2.21 | |||||
SM 24:1 | ↓ | 2.02 | |||||
PC (18:3(6Z,9Z,12Z)/18:3(6Z,9Z,12Z)) | ↓ | 2.01 | |||||
Cer-NS d27:4 | ↓ | 1.95 | |||||
PC (14:0/20:3(5Z,8Z,11Z)) | ↓ | 1.90 | |||||
PC 38:6 | ↓ | 1.88 | |||||
PC (13:0/19:0) | ↓ | 1.86 | |||||
Diisononyl phthalate | ↓ | 1.73 | |||||
DG 35:5 | ↓ | 1.65 | |||||
PC 40:6 | ↓ | 1.64 | |||||
Serylisoleucine | ↓ | 1.58 | |||||
SM d36:2 | ↓ | 1.51 | |||||
PC (18:1(9Z)/22:5(7Z,10Z,13Z,16Z,19Z)) | ↓ | 1.51 | |||||
CAY10449 | ↓ | 3.48 | |||||
Nervonic acid | ↓ | 1.96 |